Supplement of HL131017: Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes

HL131017 补充:通过心外膜 FSTL1 和 CCND2 过表达心肌细胞的心脏补片递送进行心肌再肌化

基本信息

  • 批准号:
    10797360
  • 负责人:
  • 金额:
    $ 2.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

Title: Supplement of HL131017: Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes Project Summary Despite undergoing intensive treatment regimens, patients with severe acute myocardial infarction (AMI) often end up with end stage congestive heart failure (CHF). From the molecular and cellular perspective, heart failure occurs due to the loss of the contractile unit of the left ventricle: cardiomyocytes (CMs). Therefore, promotion of myocyte proliferation and understanding the regulators of myocyte cell cycle could have highly significant impact on the management of heart failure. In this proposal, we seek to develop 3D bioengineered cardiac muscle constructs that incorporate a functional vascular network and recapitulate some of the key microenvironmental cues of native heart tissue. Our recent studies have identified main biomechanical and molecular cues that can significantly enhance cell cycle re-entry of adult CMs. We demonstrated that epicardial application of a cardiac patch, laden with follistatin like-1 (FSTL1) protein, protected the mouse and pig heart against AMI, left ventricle dilatation, and heart failure. We recently reported that overexpression of a cell cycle gene, CCND2 (cyclin D2), induces proliferation of transplanted human induced pluripotent stem cell (hiPSC) derived-CMs. This proposal builds upon our recent technological achievements, enabling cast or bioprinting of major cardiac cells and hydrogels at high spatial resolution (20 µm) to fabricate 3D perfusable vascular constructs. Our central hypothesis is that 3D cardiac constructs, laden with FSTL1 and hiPSC-CCND2 CMs, can synergistically remuscularize ischemic myocardium. We test this hypothesis in three integrated Specific Aims (SAs). In SA1, we will utilize our cast/bioprinted 3D cardiac tissue models to identify the cellular and molecular mechanisms underlying myocyte pro-proliferative effect of FSTL1 treatment in vitro. In SA2, we will assess the identified signaling pathways, involved in FSTL1-CCND2 CM-patch effect, to promote remuscularization in mouse model of MI (both acute and chronic). In SA3, we will assess the pre-clinical potential of bioengineered pre-vascularized muscle patch device in treating AMI in a pig model of ischemia-reperfusion. The open chest delivery of cardiac patches have imitations. We will compare the efficacy of open chest delivery versus a novel minimally invasive, catheter-based, pericardial delivery of FSTL1 and CCND2 CM laden muscle patch to the epicardium. The findings of this project will establish a novel generation of personalized cardiac patch devices for remuscularization of heart with postinfarction LV remodeling.
标题: HL131017 补充:通过心外膜 FSTL1 的心脏补片递送进行心肌再肌化 和 CCND2 过表达心肌细胞 项目概要 尽管接受强化治疗方案,严重急性心肌梗死 (AMI) 患者仍经常出现以下情况: 最终出现终末期充血性心力衰竭(CHF)。从分子和细胞角度来看,心力衰竭 由于左心室收缩单位心肌细胞(CM)的丧失而发生。因此,推广 心肌细胞增殖和了解心肌细胞周期的调节因子可能会产生非常显着的影响 关于心力衰竭的治疗。在此提案中,我们寻求开发 3D 生物工程心肌 包含功能性血管网络并概括一些关键微环境的构建体 原生心脏组织的线索。我们最近的研究已经确定了主要的生物力学和分子线索,可以 显着增强成体 CM 的细胞周期重入。我们证明了心脏的心外膜应用 含有卵泡抑素样 1 (FSTL1) 蛋白的贴片可保护小鼠和猪心脏免受 AMI、左心室的影响 扩张和心力衰竭。我们最近报道了细胞周期基因 CCND2(细胞周期蛋白 D2)的过度表达, 诱导移植的人类诱导多能干细胞 (hiPSC) 衍生的 CM 的增殖。这个提议 以我们最近的技术成就为基础,能够对主要心肌细胞进行铸造或生物打印, 高空间分辨率 (20 µm) 的水凝胶可制造 3D 可灌注血管结构。我们的中央 假设充满 FSTL1 和 hiPSC-CCND2 CM 的 3D 心脏结构可以协同作用 使缺血的心肌重新肌化。我们在三个综合特定目标 (SA) 中测试了这一假设。在SA1中, 我们将利用我们的铸造/生物打印 3D 心脏组织模型来识别细胞和分子机制 FSTL1 治疗体外潜在的心肌细胞增殖作用。在 SA2 中,我们将评估已识别的 参与 FSTL1-CCND2 CM 贴片效应的信号通路,促进小鼠模型的肌再化 MI(急性和慢性)。在 SA3 中,我们将评估生物工程预血管化的临床前潜力 肌肉补片装置治疗猪缺血再灌注模型中的 AMI。心脏开胸分娩 补丁有仿制品。我们将比较开胸分娩与新型微创分娩的疗效, 基于导管的心包将满载 FSTL1 和 CCND2 CM 的肌肉补片输送至心外膜。研究结果 该项目将建立新一代个性化心脏补片设备,用于肌肉再造 心脏梗死后左心室重塑。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vahid Serpooshan其他文献

Vahid Serpooshan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vahid Serpooshan', 18)}}的其他基金

Leveraging 3D bioprinted organoid constructs to pattern and model human brain development
利用 3D 生物打印类器官结构来模拟人类大脑发育
  • 批准号:
    10184225
  • 财政年份:
    2021
  • 资助金额:
    $ 2.17万
  • 项目类别:
Leveraging 3D bioprinted organoid constructs to pattern and model human brain development
利用 3D 生物打印类器官结构来模拟人类大脑发育
  • 批准号:
    10550132
  • 财政年份:
    2021
  • 资助金额:
    $ 2.17万
  • 项目类别:
Leveraging 3D bioprinted organoid constructs to pattern and model human brain development
利用 3D 生物打印类器官结构来模拟人类大脑发育
  • 批准号:
    10380006
  • 财政年份:
    2021
  • 资助金额:
    $ 2.17万
  • 项目类别:
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes
通过心脏补片递送心外膜 FSTL1 和 CCND2 过表达心肌细胞进行心肌再肌化
  • 批准号:
    10375894
  • 财政年份:
    2016
  • 资助金额:
    $ 2.17万
  • 项目类别:
Molecular and Cellular Mechanisms of Neonatal Cardiac Development and Repair
新生儿心脏发育和修复的分子和细胞机制
  • 批准号:
    9024262
  • 财政年份:
    2016
  • 资助金额:
    $ 2.17万
  • 项目类别:
Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes
通过心脏补片递送心外膜 FSTL1 和 CCND2 过表达心肌细胞进行心肌再肌化
  • 批准号:
    10538614
  • 财政年份:
    2016
  • 资助金额:
    $ 2.17万
  • 项目类别:

相似海外基金

Study on the use of 3D print models to improve understanding of geomorphic processes
研究使用 3D 打印模型来提高对地貌过程的理解
  • 批准号:
    22K13777
  • 财政年份:
    2022
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
3D print-on-demand technology for personalised medicines at the point of care
用于护理点个性化药物的 3D 按需打印技术
  • 批准号:
    10045111
  • 财政年份:
    2022
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Grant for R&D
Regenerative cooling optimisation in 3D-print rocket nozzles
3D 打印火箭喷嘴的再生冷却优化
  • 批准号:
    2749141
  • 财政年份:
    2022
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Studentship
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
  • 批准号:
    548945-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 2.17万
  • 项目类别:
    College - University Idea to Innovation Grants
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
  • 批准号:
    548945-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 2.17万
  • 项目类别:
    College - University Idea to Innovation Grants
Administrative Supplement for Equipment: 6-axis Positioner to Improve 3D Print Quality and Print Size
设备管理补充:用于提高 3D 打印质量和打印尺寸的 6 轴定位器
  • 批准号:
    10801667
  • 财政年份:
    2019
  • 资助金额:
    $ 2.17万
  • 项目类别:
SBIR Phase II: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第二阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
  • 批准号:
    1738138
  • 财政年份:
    2017
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Standard Grant
Development of "artificial muscle' ink for 3D print of microrobots
开发用于微型机器人3D打印的“人造肌肉”墨水
  • 批准号:
    17K18852
  • 财政年份:
    2017
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
I-Corps: Nanochon, a Commercial Venture to 3D Print Regenerative Implants for Joint Reconstruction
I-Corps:Nanochon,一家商业企业,致力于 3D 打印再生植入物进行关节重建
  • 批准号:
    1612567
  • 财政年份:
    2016
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Standard Grant
SBIR Phase I: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第一阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
  • 批准号:
    1621732
  • 财政年份:
    2016
  • 资助金额:
    $ 2.17万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了